HCPCS Level II code E0491 identifies a 90-day oral appliance for neuromuscular electrical stimulation of the tongue muscle, used with a separate power source and control electronics and operated via a hardware remote. This code matters nationally as oral neuromuscular stimulation devices are increasingly used in dysphagia and speech rehabilitation, where device classification and coverage policy affect patient access and clinical workflows. Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise explanation of what the code represents, typical clinical settings and service type, and the payer landscape relevant to coverage considerations. The publication summarizes benchmarks and policy-relevant themes such as coverage variability across commercial payers and Medicare, documentation and coding considerations tied to durable medical equipment classification, and clinical context regarding use for tongue muscle stimulation. Data not available in the input is noted where applicable. The piece provides operational clarity for billing, coding, and policy teams assessing access, reimbursement pathways, and administrative requirements for HCPCS Level II code E0491.